Jan 12, 2021
Making a Case for Going Beyond the Liver to Include Muscles for NAFLD: A Systematic Review Published
Nov 17, 2020
AMRA Medical Research Reveals New MRI-based Data Connected to Risk for Coronary Heart Disease at The Liver Meeting Digital Experience®
Aug 27, 2020
AMRA Researchers Make the Case for MRI Biomarkers for Neuromuscular Diseases
Aug 20, 2020
AMRA Medical Will Present a Study on MRI-Based Body Composition in Liver Disease at The Digital International Liver Congress(TM) 2020
Jun 30, 2020
AMRA Medical and the National University of Singapore Partner to Study NAFLD in Asia
Jun 23, 2020
AMRA Medical Presents Reproducibility Study of an MRI-based Body Composition Analysis Method
Apr 02, 2020
AMRA Medical and Fulcrum Therapeutics Develop MRI Method for Multi-site Neuromuscular Clinical Trials
Nov 13, 2019
AMRA Medical Abstract Selected for AASLD's "Best of The Liver Meeting" Showcase
Oct 30, 2019
AMRA Technology Added to Dallas Hearts and Minds Study, Expands AMRA's Population Database for Body Composition
Oct 23, 2019
New Study Reveals Method Linking AMRA Medical's Muscle Biomarkers and Function
Sep 10, 2019
AMRA Announces Strategic Partnership with Japanese Leading Imaging CRO, Micron, Inc., to Support Clinical Trials in Japan
May 16, 2019
AMRA Medical Announces Its Technology Has the Ability to Predict the Occurrence of Coronary Heart Disease and Type 2 Diabetes
Feb 05, 2019
AMRA Medical Appoints Allison Robbins as Chief Financial Officer
Jan 08, 2019
AMRA Medical Welcomes Rosemary Shull as Senior Vice President, Global Business Development & Marketing